What is NDC 11673-819?

11673-819 is the product NDC for Naproxen Sodium and Diphenhydramine HCL, Diphenhydramine hydrochloride 25 mg/1; Naproxen sodium 220 mg/1 tablet, listed with the FDA by TARGET CORPORATION. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Diphenhydramine hydrochloride, Naproxen sodium.

TARGET CORPORATION, NDC labeler code 11673. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Naproxen Sodium and Diphenhydramine HCL?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Naproxen Sodium and Diphenhydramine HCL NDC 11673-819

NDC codes

FDA NDC Directory

Product NDC (as listed)11673-819Labeler and product segments. Claims need a package NDC.

Product NDC at billing width11673-0819Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
11673-819-08	1167308190811673081908	80 TABLET in 1 BOTTLE (11673-819-08)Marketed from Mar 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naproxen Sodium and Diphenhydramine HCL
Generic name (nonproprietary): naproxen sodium and diphenhydramine hcl
Active ingredients: Diphenhydramine hydrochloride — 25 mg/1Naproxen sodium — 220 mg/1
Dosage form: Tablet
Route: Oral
Labeler: TARGET CORPORATIONNDC labeler code 11673
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213663
Marketing start: Mar 1, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 11673-819_46536f85-5a10-9ebe-e063-6394a90a97bdSPL ID 46536f85-5a10-9ebe-e063-6394a90a97bdSPL set ID fe82699d-fdc2-038e-e053-6294a90a606cRxCUI 1550957UNII TC2D6JAD40, 9TN87S3A3C
Pharmacologic class: Histamine-1 Receptor Antagonist; Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N411673081908 followed by a unit qualifier and the quantity

Package 11673-0819-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 19, 2025.

Indications (excerpt from the label)

Uses • for relief of occasional sleeplessness when associated with minor aches and pains • helps you fall asleep and stay asleep

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 11673-819

What is NDC 11673-819?: 11673-819 is the product NDC for Naproxen Sodium and Diphenhydramine HCL, Diphenhydramine hydrochloride 25 mg/1; Naproxen sodium 220 mg/1 tablet, listed with the FDA by TARGET CORPORATION. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Naproxen Sodium and Diphenhydramine HCL.
What is the active ingredient?: Diphenhydramine hydrochloride, Naproxen sodium.
Who is the labeler?: TARGET CORPORATION, NDC labeler code 11673. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Naproxen Sodium and Diphenhydramine HCL?: 2 other product NDCs are listed under this name. See all Naproxen Sodium and Diphenhydramine HCL NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Naproxen Sodium and Diphenhydramine HCL NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Naproxen Sodium and Diphenhydramine HCl	Naproxen sodium 220 mg/1; Diphenhydramine hydrochloride 25 mg/1	Tablet, Film coatedOral	Granules India Ltd	62207-814	62207-0814-3862207-0814-3962207-0814-47+1 more
Naproxen Sodium and Diphenhydramine HClnaproxen sodium and diphenhydramine	Naproxen sodium 220 mg/1; Diphenhydramine hydrochloride 25 mg/1	Tablet, Film coatedOral	Amneal Pharmaceuticals NY LLC	69238-1422	69238-1422-0269238-1422-0469238-1422-06+1 more

Other NDCs under ANDA 213663

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213663
Product	Strength	Form · route	Labeler	Product NDC
Naproxen Sodium and Diphenhydramine HCl	Naproxen sodium 220 mg/1; Diphenhydramine hydrochloride 25 mg/1	Tablet, Film coatedOral	Granules India Ltd	62207-814
Naproxen Sodium Diphenhydramine HCl	Naproxen sodium 220 mg/1; Diphenhydramine hydrochloride 25 mg/1	Tablet, Film coatedOral	CVS PHARMACY, INC	69842-328
Naproxen Sodium Diphenhydramine HCL	Diphenhydramine hydrochloride 25 mg/1; Naproxen sodium 220 mg/1	TabletOral	Walmart	79903-204
Naproxen Sodium Diphenhydramine Hydrochloride	Naproxen sodium 220 mg/1; Diphenhydramine hydrochloride 25 mg/1	TabletOral	SAFEWAY	21130-814